Innovent doses first patient in Phase I diabetic macular edema trial

Innovent doses first patient in Phase I diabetic macular edema trial

Submitted by admin on August 8, 2022 - 9:51am
Source: 
Clinical Trials Arena
News Tags: 
Innovent Biologics
clinical trials
IBI324
diabetic macular edema
Headline: 
Innovent doses first patient in Phase I diabetic macular edema trial
snippet: 

Innovent Biologics has dosed the first patient in the first-in-human Phase I clinical trial of IBI324 in patients with diabetic macular oedema (DME).

Do Not Allow Advertisers to Use My Personal information